Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee
The Department of Defense (referred to herein as "the Department", "Department of War" or "DoW") is publishing this notice to announce that the following Federal Advisory Commit...
Office of the Under Secretary of Defense for Personnel and Readiness (OUSD(P&R)), Department of Defense (DoD).
ACTION:
Notice of Federal Advisory Committee meeting.
SUMMARY:
The Department of Defense (referred to herein as “the Department”, “Department of War” or “DoW”) is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (UF BAP) will take place.
DATES:
Open to the public.
Monday, June 22nd, 10:00 a.m.-1:00 p.m. (Eastern Standard Time).
ADDRESSES:
The meeting will be held telephonically or via conference call. The phone number for remote access is: 1-667-892-3500 or 1-667-892-3600.
Due to circumstances beyond the control of the Designated Federal Officer and the DoW, the UFBAP was unable to provide public notification required by 41 Code of Federal Regulations (CFR) 102-3.150(a) concerning its June 22, 2026 meeting. Accordingly, the Advisory Committee Management Officer for the DoW, pursuant to 41 CFR 102-3.150(b), waives the 15-calendar day notification requirement. This meeting is held under the provisions of chapter 10 of title 5, United States Code (U.S.C.) (commonly known as the Federal Advisory Committee Act or FACA) and 41 CFR 102-3.140 and 102-3.150.
Purpose of the Meeting:
The UF BAP will review and comment on recommendations made by the Pharmacy and Therapeutics Committee to the Director, Defense Health Agency regarding the Uniform Formulary.
Agenda
1. 10:00 a.m.-10:10 a.m. Sign in for UF BAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
a. Welcome, Opening Remarks, and Introduction of UF BAP Members by CAPT Phung Thien Nguyen, DFO, UF BAP
b. Public Written Comments by CAPT Phung Thien Nguyen, ADFO, UF BAP
c. Opening Remarks by Jon Ostrowski, UF BAP Member
d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary Management Branch
Meeting Accessibility:
Pursuant to section 1009(a)(1) of title 5, U.S.C. and 41 CFR 102-3.140 through 102-3.165, and subject to the availability of phone lines, the meeting is open to the public. Telephone lines are limited and available to the first 220 people dialing in. There will be 220 lines total: 200 domestic and 20 international, including leader lines.
Written Statements:
Pursuant to 41 CFR 102-3.105(j) and 102-3.140(c), and section 1009(a)(3) of title 5, U.S.C., interested persons or organizations may submit written statements to the UF BAP about its mission and/or the agenda to be addressed in the public meetings. Written statements should be submitted to the UF BAP's ADFO. The ADFO's contact information can be found in the
FOR FURTHER INFORMATION CONTACT:
Written comments or statements received are releasable to the public. The DFO will review all submitted written statements and provide copies to UF BAP.
Dated: June 18, 2026.
Stephanie J. Bost,
Alternate OSD Federal Register Liaison Officer, Department of Defense.